Cryoport Systems’ Temperature-Controlled Supply Chain Blog
04/16/2024
Overcoming Industry Obstacles for Cell and Gene Therapy Development
In the rapidly advancing world of cell and gene therapy (CGT) development, finding the proper solution to overcome common industry obstacles is a challenge that can impact entire production timelines.
04/09/2024
National Holiday Facility Closures
As we look to the rest of 2024, Cryoport Systems wants to ensure that you’re up to date on our service schedule.
03/27/2024
Tec4med: The Newest Addition to Cryoport’s Team
Cryoport Systems is a part of a nexus of supply chain solutions companies all under Cryoport, Inc. The other business units are CRYOGENE, CRYOPDP, and MVE Biological Solutions...
02/22/2024
Examining 2023 & 2024: What’s to Come with President & CEO, Mark Sawicki
The cell and gene therapy industry is poised for many changes in 2024. With persistent challenges facing manufacturers and developers such as the retention of experienced talent or a general lack of funding for specialized therapies, the state of what’s to come feels more unsure than it has in recent years.
02/06/2024
Enabling the Outcome with Cryoport Systems
Cryoport Systems entered the market over two decades ago to support the logistics processes of life sciences organizations. As industry demands evolved, our logistics capabilities expanded into a robust platform of supply chain management offerings.
01/18/2024
Ring in the Rebrand: Nasdaq Bell Ringing Ceremony Recording
Cryoport Systems started off the New Year strong with the unveiling of our rebrand, which includes succinct looks for our parent and sibling companies. On January 17th, we were fortunate enough...
12/31/2023
